DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Chapter Twelve - Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease

Abstract

HIV-1 protease is an essential therapeutic target for the design and development of antiviral inhibitors to treat AIDS. We used room temperature neutron crystallography to accurately determine hydrogen atom positions in several protease complexes with clinical drugs, amprenavir and darunavir. Hydrogen bonding interactions were carefully mapped to provide an unprecedented picture of drug binding to the protease target. We demonstrate that hydrogen atom positions within the enzyme catalytic site can be altered by introducing drug resistant mutations and by protonating surface residues that trigger proton transfer reactions between the catalytic Asp residues and the hydroxyl group of darunavir. When protein perdeuteration is not feasible, we validate the use of initial H/D exchange with unfolded protein and partial deuteration in pure D2O with hydrogenous glycerol to maximize deuterium incorporation into the protein, with no detrimental effects on the growth of quality crystals suitable for neutron diffraction experiments.

Authors:
ORCiD logo [1];  [2];  [2]; ORCiD logo [1];  [3];  [4];  [5];  [6]
  1. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
  2. Tennessee Wesleyan Univ., Athens, TN (United States)
  3. Science and Technology Facilities Council (STFC), Oxford (United Kingdom). Rutherford Appleton Lab. (RAL)
  4. Inst. Laue-Langevin (ILL), Grenoble (France)
  5. Georgia State Univ., Atlanta, GA (United States)
  6. National Inst. of Health (NIH), Bethesda, MD (United States)
Publication Date:
Research Org.:
Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1606039
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
Methods in Enzymology
Additional Journal Information:
Journal Volume: 634; Journal Issue: 1; Journal ID: ISSN 0076-6879
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; Human immunodeficiency virus type 1; Acquired immunodeficiency syndrome; HIV-1 protease; Structure-assisted drug design; Clinical protease inhibitor; Neutron crystallography; Protonation state; Proton transfer; Hydrogen bond

Citation Formats

Kovalevsky, Andrii Y., Beltran, Kaira, Gerlits, Oksana, Weiss, Kevin L., Keen, David A., Blakeley, Matthew P., Weber, Irene, and Louis, John M. Chapter Twelve - Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease. United States: N. p., 2020. Web. doi:10.1016/bs.mie.2019.12.002.
Kovalevsky, Andrii Y., Beltran, Kaira, Gerlits, Oksana, Weiss, Kevin L., Keen, David A., Blakeley, Matthew P., Weber, Irene, & Louis, John M. Chapter Twelve - Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease. United States. https://doi.org/10.1016/bs.mie.2019.12.002
Kovalevsky, Andrii Y., Beltran, Kaira, Gerlits, Oksana, Weiss, Kevin L., Keen, David A., Blakeley, Matthew P., Weber, Irene, and Louis, John M. Sun . "Chapter Twelve - Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease". United States. https://doi.org/10.1016/bs.mie.2019.12.002. https://www.osti.gov/servlets/purl/1606039.
@article{osti_1606039,
title = {Chapter Twelve - Proton transfer and drug binding details revealed in neutron diffraction studies of wild-type and drug resistant HIV-1 protease},
author = {Kovalevsky, Andrii Y. and Beltran, Kaira and Gerlits, Oksana and Weiss, Kevin L. and Keen, David A. and Blakeley, Matthew P. and Weber, Irene and Louis, John M.},
abstractNote = {HIV-1 protease is an essential therapeutic target for the design and development of antiviral inhibitors to treat AIDS. We used room temperature neutron crystallography to accurately determine hydrogen atom positions in several protease complexes with clinical drugs, amprenavir and darunavir. Hydrogen bonding interactions were carefully mapped to provide an unprecedented picture of drug binding to the protease target. We demonstrate that hydrogen atom positions within the enzyme catalytic site can be altered by introducing drug resistant mutations and by protonating surface residues that trigger proton transfer reactions between the catalytic Asp residues and the hydroxyl group of darunavir. When protein perdeuteration is not feasible, we validate the use of initial H/D exchange with unfolded protein and partial deuteration in pure D2O with hydrogenous glycerol to maximize deuterium incorporation into the protein, with no detrimental effects on the growth of quality crystals suitable for neutron diffraction experiments.},
doi = {10.1016/bs.mie.2019.12.002},
journal = {Methods in Enzymology},
number = 1,
volume = 634,
place = {United States},
year = {Sun Mar 01 00:00:00 EST 2020},
month = {Sun Mar 01 00:00:00 EST 2020}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 2 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes
journal, January 2001

  • Mahalingam, Bhuvaneshwari; Louis, John M.; Hung, Jason
  • Proteins: Structure, Function, and Genetics, Vol. 43, Issue 4
  • DOI: 10.1002/prot.1057

Direct determination of protonation states and visualization of hydrogen bonding in a glycoside hydrolase with neutron crystallography
journal, September 2015

  • Wan, Qun; Parks, Jerry M.; Hanson, B. Leif
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 40
  • DOI: 10.1073/pnas.1504986112

Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
journal, January 2016


Ionization states of the catalytic residues in HIV-1 protease
journal, November 1996

  • Smith, Ross; Brereton, Ian M.; Chai, Richard Y.
  • Nature Structural Biology, Vol. 3, Issue 11
  • DOI: 10.1038/nsb1196-946

Ionization state of the catalytic dyad Asp25/25′ in the HIV-1 protease: NMR studies of site-specifically 13C labelled HIV-1 protease prepared by total chemical synthesis
journal, January 2012

  • Torbeev, Vladimir Yu.; Kent, Stephen B. H.
  • Organic & Biomolecular Chemistry, Vol. 10, Issue 30
  • DOI: 10.1039/c2ob25569c

Neutron Crystallography for the Study of Hydrogen Bonds in Macromolecules
journal, April 2017


Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV
journal, January 2012

  • Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.
  • Angewandte Chemie International Edition, Vol. 51, Issue 8
  • DOI: 10.1002/anie.201102762

Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography
journal, March 2009

  • Adachi, M.; Ohhara, T.; Kurihara, K.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 12
  • DOI: 10.1073/pnas.0809400106

Neutron protein crystallography: A complementary tool for locating hydrogens in proteins
journal, July 2016

  • O'Dell, William B.; Bodenheimer, Annette M.; Meilleur, Flora
  • Archives of Biochemistry and Biophysics, Vol. 602
  • DOI: 10.1016/j.abb.2015.11.033

Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114
journal, October 2006

  • Kovalevsky, Andrey Y.; Liu, Fengling; Leshchenko, Sofiya
  • Journal of Molecular Biology, Vol. 363, Issue 1
  • DOI: 10.1016/j.jmb.2006.08.007

A suite-level review of the neutron single-crystal diffraction instruments at Oak Ridge National Laboratory
journal, September 2018

  • Coates, L.; Cao, H. B.; Chakoumakos, B. C.
  • Review of Scientific Instruments, Vol. 89, Issue 9
  • DOI: 10.1063/1.5030896

Joint X-ray/Neutron Crystallographic Study of HIV-1 Protease with Clinical Inhibitor Amprenavir: Insights for Drug Design
journal, June 2013

  • Weber, Irene T.; Waltman, Mary Jo; Mustyakimov, Marat
  • Journal of Medicinal Chemistry, Vol. 56, Issue 13
  • DOI: 10.1021/jm400684f

Sub-atomic resolution X-ray crystallography and neutron crystallography: promise, challenges and potential
journal, June 2015


Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
journal, January 2010

  • Mehellou, Youcef; De Clercq, Erik
  • Journal of Medicinal Chemistry, Vol. 53, Issue 2
  • DOI: 10.1021/jm900492g

The Low-Barrier Double-Well Potential of the O δ 1 −H−O δ 1 Hydrogen Bond in Unbound HIV Protease:  A QM/MM Characterization
journal, August 2006

  • Porter, Melissa A.; Molina, Pablo A.
  • Journal of Chemical Theory and Computation, Vol. 2, Issue 6
  • DOI: 10.1021/ct600200s

HIV-1 Protease with 20 Mutations Exhibits Extreme Resistance to Clinical Inhibitors through Coordinated Structural Rearrangements
journal, March 2012

  • Agniswamy, Johnson; Shen, Chen-Hsiang; Aniana, Annie
  • Biochemistry, Vol. 51, Issue 13
  • DOI: 10.1021/bi2018317

HIV-1 Protease: Structural Perspectives on Drug Resistance
journal, December 2009

  • Weber, Irene; Agniswamy, Johnson
  • Viruses, Vol. 1, Issue 3
  • DOI: 10.3390/v1031110

A mechanistic theory to explain the efficacy of antiretroviral therapy
journal, September 2014

  • Laskey, Sarah B.; Siliciano, Robert F.
  • Nature Reviews Microbiology, Vol. 12, Issue 11
  • DOI: 10.1038/nrmicro3351

Defining HIV-1 Protease Substrate Selectivity
journal, March 2002

  • Beck, Z.; Morris, G.; Elder, J.
  • Current Drug Target -Infectious Disorders, Vol. 2, Issue 1
  • DOI: 10.2174/1568005024605837

Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors
journal, January 2012

  • Tie, Yunfeng; Wang, Yuan-Fang; Boross, Peter I.
  • Protein Science, Vol. 21, Issue 3
  • DOI: 10.1002/pro.2019

Follow the Protons:  A Low-Barrier Hydrogen Bond Unifies the Mechanisms of the Aspartic Proteases
journal, October 2001

  • Northrop, Dexter B.
  • Accounts of Chemical Research, Vol. 34, Issue 10
  • DOI: 10.1021/ar000184m

Highly resistant HIV-1 proteases and strategies for their inhibition
journal, June 2015

  • Weber, Irene T.; Kneller, Daniel W.; Wong-Sam, Andres
  • Future Medicinal Chemistry, Vol. 7, Issue 8
  • DOI: 10.4155/fmc.15.44

Zooming in on protons: Neutron structure of protein kinase A trapped in a product complex
journal, March 2019

  • Gerlits, Oksana; Weiss, Kevin L.; Blakeley, Matthew P.
  • Science Advances, Vol. 5, Issue 3
  • DOI: 10.1126/sciadv.aav0482

Seeing the chemistry in biology with neutron crystallography
journal, January 2013

  • Langan, Paul; Chen, Julian C. -H.
  • Physical Chemistry Chemical Physics, Vol. 15, Issue 33
  • DOI: 10.1039/c3cp51760h

Long-Range Electrostatics-Induced Two-Proton Transfer Captured by Neutron Crystallography in an Enzyme Catalytic Site
journal, March 2016

  • Gerlits, Oksana; Wymore, Troy; Das, Amit
  • Angewandte Chemie International Edition, Vol. 55, Issue 16
  • DOI: 10.1002/anie.201509989

Room Temperature Neutron Crystallography of Drug Resistant HIV-1 Protease Uncovers Limitations of X-ray Structural Analysis at 100 K
journal, February 2017


Fast and Reliable Thermodynamic Approach for Determining the Protonation State of the Asp Dyad
journal, August 2017

  • Huang, Jinfeng; Sun, Bin; Yao, Yuan
  • Journal of Chemical Information and Modeling, Vol. 57, Issue 9
  • DOI: 10.1021/acs.jcim.7b00207

Visualizing the Bohr effect in hemoglobin: neutron structure of equine cyanomethemoglobin in the R state and comparison with human deoxyhemoglobin in the T state
journal, June 2016

  • Dajnowicz, Steven; Seaver, Sean; Hanson, B. Leif
  • Acta Crystallographica Section D Structural Biology, Vol. 72, Issue 7
  • DOI: 10.1107/S2059798316009049